Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
+6.4%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$22.5B
AUM Growth
+$1.51B
(+7.2%)
Cap. Flow
+$525M
Cap. Flow
% of AUM
2.33%
Top 10 Holdings %
Top 10 Hldgs %
11.02%
Holding
1,345
New
342
Increased
297
Reduced
263
Closed
321
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$454M |
| 2 |
Amazon
AMZN
|
$409M |
| 3 |
Micron Technology
MU
|
$206M |
| 4 |
Coca-Cola
KO
|
$167M |
| 5 |
Biogen
BIIB
|
$139M |
Top Sells
| 1 |
Salesforce
CRM
|
$449M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
$274M |
| 3 |
Uber
UBER
|
$264M |
| 4 |
IBM
IBM
|
$223M |
| 5 |
Nike
NKE
|
$186M |
Sector Composition
| 1 | Healthcare | 25.06% |
| 2 | Technology | 23% |
| 3 | Consumer Discretionary | 11.81% |
| 4 | Financials | 7.3% |
| 5 | Industrials | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Alphabet (Google) Class C
GOOG
$2.84T
| $15M | 0.06% |
104,000
-6,000
| -5% | -$868K |
|
|
TSVT
377
DELISTED
2seventy bio
TSVT
| $15M | 0.06% |
+586,707
| New | +$15M |
|
378
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $15M | 0.06% |
184,690
| – | – |
|
|
VRAY
379
DELISTED
ViewRay, Inc.
VRAY
| $15M | 0.06% |
2,718,379
+1,299,811
| +92% | +$7.16M |
|
380
Dyne Therapeutics
DYN
$2.02B
| $14.9M | 0.06% |
1,254,800
+427,800
| +52% | +$5.09M |
|
|
PETQ
381
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $14.9M | 0.06% |
+655,546
| New | +$14.9M |
|
382
Hormel Foods
HRL
$14.1B
| $14.9M | 0.06% |
304,374
+45,626
| +18% | +$2.23M |
|
|
GCAC
383
DELISTED
Growth Capital Acquisition Corp. Class A Common Stock
GCAC
| $14.8M | 0.06% |
1,491,609
| – | – |
|
384
Wendy's
WEN
$1.97B
| $14.5M | 0.06% |
607,899
+69,399
| +13% | +$1.66M |
|
385
CDW
CDW
$22.2B
| $14.4M | 0.06% |
+70,400
| New | +$14.4M |
|
386
Huntington Ingalls Industries
HII
$10.6B
| $14.4M | 0.06% |
+77,100
| New | +$14.4M |
|
|
RVNC
387
DELISTED
Revance Therapeutics, Inc.
RVNC
| $14.4M | 0.06% |
881,482
+126,682
| +17% | +$2.07M |
|
|
SAGE
388
DELISTED
Sage Therapeutics
SAGE
| $14.3M | 0.06% |
336,900
-420,500
| -56% | -$17.9M |
|
|
AMED
389
DELISTED
Amedisys
AMED
| $14.3M | 0.06% |
+88,399
| New | +$14.3M |
|
390
PTC Therapeutics
PTCT
$4.55B
| $14.1M | 0.06% |
355,100
-164,300
| -32% | -$6.54M |
|
391
Petco
WOOF
$1.03B
| $14.1M | 0.06% |
713,379
+699,987
| +5,227% | +$13.9M |
|
|
SI
392
DELISTED
Silvergate Capital Corporation
SI
| $14.1M | 0.06% |
94,900
-215,300
| -69% | -$31.9M |
|
393
Adicet Bio
ACET
$60M
| $14.1M | 0.06% |
803,900
-471,100
| -37% | -$8.24M |
|
394
Martin Marietta Materials
MLM
$37.5B
| $14M | 0.06% |
31,837
-23,157
| -42% | -$10.2M |
|
395
SM Energy
SM
$3.09B
| $14M | 0.06% |
474,421
-99,222
| -17% | -$2.93M |
|
396
BP
BP
$87.4B
| $13.9M | 0.06% |
523,597
-1,170,882
| -69% | -$31.2M |
|
397
Green Plains
GPRE
$698M
| $13.9M | 0.06% |
399,048
+280,948
| +238% | +$9.77M |
|
398
DaVita
DVA
$9.86B
| $13.8M | 0.06% |
121,486
+84,386
| +227% | +$9.6M |
|
399
CME Group
CME
$94.4B
| $13.7M | 0.05% |
60,032
-63,600
| -51% | -$14.5M |
|
400
Lear
LEA
$5.91B
| $13.7M | 0.05% |
74,729
-3,010
| -4% | -$551K |
|